Business
CryoFuture Secures Liss Capital Investment After Clinic Growth
CryoFuture secures Liss Capital funding after Mid Iowa Fertility, FSAC, and three other clinics outsource long-term specimen storage to the company.
Business
CryoFuture secures Liss Capital funding after Mid Iowa Fertility, FSAC, and three other clinics outsource long-term specimen storage to the company.
Policy
New DOL rules clarify excepted benefit pathways for fertility coverage. Progyny's 9% stock drop signals concerns about margin compression as drug costs fall.
Business
Private equity firms control 30% of U.S. IVF cycles. Analysis shows 27% more treatments and 14% higher success rates, but concerns about costs and access remain.